TD Cowen Maintains Genmab(GMAB.US) With Hold Rating

Moomoo NewsDec 13 07:31 ET · Ratings

TD Cowen Reaffirms Their Hold Rating on Genmab (GMAB)

TipRanksDec 13 07:26 ET · Ratings

RBC Capital Keeps Their Buy Rating on Genmab A/S (0MGB)

TipRanksDec 12 20:51 ET · Ratings

Top Gap Ups and Downs on Thursday: CIEN, WBD, ADBE and More

Moomoo NewsDec 12 18:00 ET · Markets

Genmab to Hold 2024 R&D Update and ASH Data Review Meeting

GlobeNewswireDec 11 08:20 ET

City of Hope Reports Novel Immunotherapy in Clinical Trial Shows Promise for Patients With Relapsed or Difficult to Treat Chronic Lymphocytic Leukemia (CLL)

BusinesswireDec 10 08:00 ET